Literature DB >> 1677263

Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment.

G Chouinard1.   

Abstract

Tardive dyskinesia is thought to result from neostriatal dopaminergic receptor supersensitivity induced by chronic treatment with neuroleptics. Similarly, receptor supersensitivity occurring in other dopaminergic regions of the brain could result in the development of supersensitivity psychosis. As with tardive dyskinesia, severe forms of the disorder are rare. Ten such cases are described whose main characteristic is that psychotic symptoms can no longer be masked by increased dosages of neuroleptics. Diagnostic criteria for the disorder are proposed, and treatment with antiepileptic medication is described.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677263     DOI: 10.1016/0920-9964(91)90050-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Aripiprazole-induced seizure: a second case report.

Authors:  Che-Lin Yueh; Sung-Lin Yu; Hsiao-Min Chen; Bo-Jian Wu; Wen-Ching Chen
Journal:  BMJ Case Rep       Date:  2009-07-14

Review 2.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

3.  Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients.

Authors:  Paul Fallon; Serdar Dursun; Bill Deakin
Journal:  Ther Adv Psychopharmacol       Date:  2012-02

Review 4.  Is schizophrenia a dopamine supersensitivity psychotic reaction?

Authors:  Mary V Seeman; Philip Seeman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-12       Impact factor: 5.067

Review 5.  Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report.

Authors:  Mina Fukai; Tetsu Hirosawa; Tetsuya Takahashi; Reizo Kaneda; Mitsuru Kikuchi; Yoshio Minabe
Journal:  Ther Adv Psychopharmacol       Date:  2016-12-02

6.  Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.

Authors:  Maryann K Jacob; Peter Ash; W Edward Craighead
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-01-17       Impact factor: 4.785

7.  Attempting to stop antipsychotic medication: success, supports, and efforts to cope.

Authors:  Miriam Larsen-Barr; Fred Seymour; John Read; Kerry Gibson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-04-23       Impact factor: 4.328

8.  Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use.

Authors:  Hakan Karaş; Mehmet Güdük; Ömer Saatcioğlu
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

9.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

10.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.